1. Home
  2. CSWC vs SANA Comparison

CSWC vs SANA Comparison

Compare CSWC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital Southwest Corporation

CSWC

Capital Southwest Corporation

N/A

Current Price

$21.72

Market Cap

1.3B

ML Signal

N/A

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

N/A

Current Price

$3.12

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSWC
SANA
Founded
1961
2018
Country
United States
United States
Employees
30
N/A
Industry
Textiles
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CSWC
SANA
Price
$21.72
$3.12
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$23.50
$7.50
AVG Volume (30 Days)
577.3K
1.9M
Earning Date
01-01-0001
06-10-2026
Dividend Yield
11.63%
N/A
EPS Growth
N/A
17.24
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.83
N/A
Revenue Next Year
$10.26
N/A
P/E Ratio
$12.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.47
$1.27
52 Week High
$23.84
$6.55

Technical Indicators

Market Signals
Indicator
CSWC
SANA
Relative Strength Index (RSI) 36.18 30.88
Support Level $21.37 $2.85
Resistance Level $23.06 $3.24
Average True Range (ATR) 0.54 0.25
MACD -0.09 -0.08
Stochastic Oscillator 20.25 6.55

Price Performance

Historical Comparison
CSWC
SANA

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Share on Social Networks: